Cosmetic (aesthetic) indications only
Conditions
Interventions
None listed
Sponsors
Tokyo Chuo Beauty Clinic, Umeda Osaka Ekimae Clinic
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: Patients undergoing aesthetic surgery during the study period ASA-PS I-II Written informed consent obtained Intravenous sedation performed using the UMEDA protocol
Exclusion criteria
Exclusion criteria: Refusal or inability to provide informed consent Known allergy to propofol components (soybean/egg derivatives) Severe cardiopulmonary or psychiatric disorders deemed inappropriate by investigators Emergency cases
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| 1. Major cardiopulmonary events SpO2 < 93% lasting >= 30 seconds Systolic blood pressure deviation > +/-30% from baseline Need for urgent airway intervention 2. Patient satisfaction score (1-5) | — |
Secondary
| Measure | Time frame |
|---|---|
| Intra-operative recall (none / induction-or-emergence only / continuous to binary analysis) Recovery time (anesthetic stop to exit) Adverse symptoms (nausea, dizziness, dyspnea, unsteadiness, etc.) Desire to receive the same sedation again (Yes/No) | — |
Countries
Japan
Contacts
Public ContactKeisuke Matsumura
Tokyo Chuo Beauty Clinic, Umeda Osaka Ekimae Clinic Tokyo Chuo Beauty Clinic, Umeda Osaka Ekimae Clinic
Outcome results
None listed